HK-based Insilico closes $60m & 33 more deal updates from Greater China worth $1.6b

HK-based Insilico closes $60m & 33 more deal updates from Greater China worth $1.6b

Alex Zhavoronkov, founder and CEO of Hong Kong-based Insilico Medicine

06 June, 2022

AI drug discovery Insilico Medicine Warburg Pincus

Printed by Unregistered user on Sun, 14 Dec 2025 00:09:44 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

Seek Pet raises $75m and 21 more deal updates from Greater China worth $263m

Greater China fundraising slows in Q1 2022 as PE-VC interest in megadeals wanes

Read more from Greater China

JD.com pledges $3.12b housing support for delivery riders

Venture Capital

HongShan-backed GenAI startup DIP raises nearly $50m Series D funding